超音波組織消融系統市場規模、佔有率和成長分析：按產品類型、系統便攜性、臨床應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球超音波組織消融系統市場價值為 6.2146 億美元，預計到 2033 年將從 2025 年的 6.7627 億美元成長至 13.2982 億美元，在預測期（2026-2033 年）內複合年成長率為 8.82%。

由於對非侵入性治療的需求不斷成長，全球超音波組織消融系統市場正經歷顯著成長。非侵入性治療能夠縮短住院時間並減少併發症。隨著慢性肝病和固態腫瘤的日益增多，需要消融治療的患者數量也不斷增加。壓電換能器設計和影像整合的技術創新正在提高手術安全性，並將市場關注點從手術器械轉向治療解決方案。此外，監管支持和保險報銷改革，例如美國醫療保險（Medicare）超音波肝臟消融納入醫保範圍，也推動了這些設備的普及。人工智慧驅動的自動化技術透過實現即時調整、提高安全性和最佳化工作流程，增強了設備的效能。這些因素共同促進了臨床醫生對這些設備的接受度，並擴大了市場機會。

全球超音波組織消融系統市場的成長要素

由於醫療專業人員對超音波組織消融技術的支持度不斷提高，全球超音波組織消融系統市場正在成長。其微創特性是關鍵因素，可縮短恢復時間並最大限度地減少患者的不適感。精準的能量傳遞能力顯著降低了對周圍組織的損傷，使臨床醫生在治療各種疾病時更有信心。這種信心的增強正在擴大醫療機構提供的治療範圍，並推動對該技術的進一步投資。隨著越來越多的臨床醫生透過全面的培訓和高效工作流程的整合累積經驗，超音波消融系統在各個醫學專科中的普及程度持續上升。

全球超音波組織消融系統市場的限制因素

全球超音波組織消融系統市場面臨諸多限制因素，其中之一便是這些系統實施成本高昂。這些成本不僅包括主機，還包括必要的成像組件和持續使用的耗材。如此沉重的經濟負擔迫使醫院和診所撥出大量預算，往往導致它們難以將這些系統置於其他資本投資需求之上。因此，小規模的醫療機構和資源有限的機構可能特別不願意採用這些技術。這一經濟障礙正在減緩市場滲透速度，決策者通常選擇分階段升級而非徹底更換系統，這在確定其更明確的成本效益之前，會阻礙整體市場成長。

超音波組織消融系統的全球市場趨勢

全球超音波組織消融系統市場的一個顯著趨勢是將高解析度成像技術整合到系統中，以改善手術過程中的即時視覺化效果。臨床醫生擴大將高解析度影像技術與消融平台結合使用，從而在保護鄰近健康組織的同時，精準靶向病變組織。這種從傳統外科手術方法向影像引導的微創技術的轉變，不僅改善了患者的治療效果，還縮短了恢復時間並減少了併發症。為此，製造商正在將超音波、磁振造影 (MRI) 和光學同調斷層掃描(OCT) 等先進成像功能整合到其消融系統中，從而簡化工作流程並擴展其在包括腫瘤學、循環系統和整形外科在內的各個醫學領域的應用範圍。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球超音波組織消融系統市場規模：依產品類型分類

• 高強度聚焦超音波系統
• 磁振造影（MRI）引導聚焦超音波系統
• 超音波外科消融系統
• 衝擊波治療系統

全球超音波組織消融系統市場規模：系統便攜性

• 獨立主機系統
• 緊湊型可攜式系統

全球超音波組織消融系統市場規模：依臨床應用分類

• 婦科疾病
  • 子宮肌瘤
  • 子宮肌腺症
• 癌症治療
  • 攝護腺癌
  • 肝腫瘤
  • 乳癌
• 神經病變
• 心血管疾病
• 泌尿系統疾病
• 其他

全球超音波組織消融系統市場規模：依最終用戶分類

• 醫院
• 專科癌症中心
• 診斷影像中心
• 門診手術中心
• 其他

全球超音波組織消融系統市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Johnson & Johnson
• Medtronic plc
• Olympus Corporation
• Insightec Ltd.
• SonaCare Medical, LLC
• Bioventus LLC
• Alpinion Medical Systems Co., Ltd.
• Advanced Medical Solutions Group plc
• Theraclion SA
• Chongqing Haifu Medical Technology Co., Ltd.
• EDAP TMS SA
• FUSMobile Inc.
• Monteris Medical Inc.
• Soring GmbH
• Bioventus
• Striker Corporation
• Integra LifeSciences Holdings Corporation
• Bowa Medical
• Shenzhen Promethe Medical Sci-Tech Co., Ltd.
• Mianyang Sonic Electronic Co., Ltd.

結論與建議

Global Ultrasonic Tissue Ablation System Market size was valued at USD 621.46 Million in 2024 and is poised to grow from USD 676.27 Million in 2025 to USD 1329.82 Million by 2033, growing at a CAGR of 8.82% during the forecast period (2026-2033).

The global ultrasonic tissue ablation system market is experiencing significant growth due to the increasing demand for non-invasive therapies that reduce hospital stays and complications. The rise in chronic liver disease and solid tumors leads to a higher patient pipeline needing ablation treatments. Innovations in piezoelectric transducer design and imaging integration have improved procedural safety, shifting the market focus from surgical tools to therapeutic solutions. Additionally, favorable regulatory support and reimbursement reforms are encouraging the adoption of these devices, as seen in the U.S. with Medicare coverage for ultrasonic liver ablation. Furthermore, AI-driven automation is enhancing device capabilities by enabling real-time adjustments, improving safety, and optimizing workflows, thus driving clinician adoption and expanding market opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ultrasonic Tissue Ablation System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ultrasonic Tissue Ablation System Market Segments Analysis

Global ultrasonic tissue ablation system market is segmented by product type, system portability, clinical application, end user and region. Based on product type, the market is segmented into High-Intensity Focused Ultrasound Systems, Magnetic Resonance-Guided Focused Ultrasound Systems, Ultrasonic Surgical Ablation Systems and Shockwave Therapy Systems. Based on system portability, the market is segmented into Standalone Console Systems and Compact Portable Systems. Based on clinical application, the market is segmented into Gynecologic Disorders, Oncology Treatment, Neurological Disorders, Cardiovascular Disease, Urological Disorders and Others. Based on end user, the market is segmented into Hospitals, Specialized Cancer Centers, Imaging Centers, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ultrasonic Tissue Ablation System Market

The global market for ultrasonic tissue ablation systems is experiencing growth due to the increasing endorsement of this technology among healthcare professionals, mainly attributable to its minimally invasive characteristics that decrease recovery times and minimize discomfort for patients. The ability to deliver energy with precision significantly reduces collateral damage, instilling greater confidence in clinicians when addressing a range of medical conditions. This trust leads to an expanded array of procedures offered by healthcare facilities, prompting further investments in the technology. As more clinicians gain experience through enhanced training and effective workflow integration, the popularity of ultrasonic ablation systems continues to rise across various medical specialties.

Restraints in the Global Ultrasonic Tissue Ablation System Market

The Global Ultrasonic Tissue Ablation System market faces significant restraints due to the high acquisition costs associated with these systems. The expenses involved encompass not only the primary device but also essential imaging components and ongoing consumables. This financial burden necessitates that hospitals and clinics allocate considerable budgetary resources, which can often lead to prioritization challenges against other capital needs. As a result, smaller or resource-limited facilities may be particularly hesitant to adopt such technology. This financial obstacle contributes to a slower rate of market penetration, with decision-makers typically opting for gradual upgrades instead of complete system changes, thereby hindering overall market growth until clearer cost-effectiveness is established.

Market Trends of the Global Ultrasonic Tissue Ablation System Market

The Global Ultrasonic Tissue Ablation System market is witnessing a significant trend towards the integration of precision imaging technologies, which enhance real-time visualization during procedures. Clinicians are increasingly leveraging high-resolution imaging modalities in conjunction with ablation platforms to ensure precise targeting of pathological tissues while sparing adjacent healthy structures. This transition from traditional surgical methods to image-guided, minimally invasive techniques is not only improving patient outcomes but also shortening recovery times and reducing complications. In response, manufacturers are incorporating advanced imaging capabilities, such as ultrasound, MRI, and optical coherence tomography, into their ablation systems, facilitating smoother workflows and broadening applications across various medical fields, including oncology, cardiology, and orthopedics.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Ultrasonic Tissue Ablation System Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• High-Intensity Focused Ultrasound Systems
• Magnetic Resonance-Guided Focused Ultrasound Systems
• Ultrasonic Surgical Ablation Systems
• Shockwave Therapy Systems

Global Ultrasonic Tissue Ablation System Market Size by System Portability & CAGR (2026-2033)

• Market Overview
• Standalone Console Systems
• Compact Portable Systems

Global Ultrasonic Tissue Ablation System Market Size by Clinical Application & CAGR (2026-2033)

• Market Overview
• Gynecologic Disorders
  • Uterine Fibroids
  • Adenomyosis
• Oncology Treatment
  • Prostate Cancer
  • Liver Tumors
  • Breast Tumors
• Neurological Disorders
• Cardiovascular Disease
• Urological Disorders
• Others

Global Ultrasonic Tissue Ablation System Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialized Cancer Centers
• Imaging Centers
• Ambulatory Surgical Centers
• Others

Global Ultrasonic Tissue Ablation System Market Size & CAGR (2026-2033)

• North America (Product Type, System Portability, Clinical Application, End User)
  • US
  • Canada
• Europe (Product Type, System Portability, Clinical Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, System Portability, Clinical Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, System Portability, Clinical Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, System Portability, Clinical Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insightec Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SonaCare Medical, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alpinion Medical Systems Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Medical Solutions Group plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theraclion SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chongqing Haifu Medical Technology Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EDAP TMS S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUSMobile Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Monteris Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soring GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Striker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bowa Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Promethe Medical Sci-Tech Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mianyang Sonic Electronic Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations